These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25995319)

  • 21. Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy.
    Aarones M; Gullestad L; Aakhus S; Ueland T; Skaardal R; Aass H; Wergeland R; Smith HJ; Aukrust P; Kongsgaard E
    Am Heart J; 2011 Jun; 161(6):1031-7. PubMed ID: 21641347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cardiac-related circulating microRNA profile in human chronic heart failure.
    Li H; Fan J; Yin Z; Wang F; Chen C; Wang DW
    Oncotarget; 2016 Jan; 7(1):33-45. PubMed ID: 26683101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adrenomedullin plasma levels as indicators of prognosis after cardiac resynchronization therapy].
    Del Ry S; Piacenti M; Cabiati M; Startari U; Caselli C; Panchetti L; Prescimone T; Rossi A; Giannessi D; Morales MA
    Recenti Prog Med; 2010 Dec; 101(12):475-9. PubMed ID: 21394984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA, emerging role as a biomarker of heart failure.
    Kawashima T; Shioi T
    Circ J; 2011; 75(2):268-9. PubMed ID: 21206130
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac resynchronization therapy and its role in the management of heart failure.
    McAloon CJ; Theodoreson MD; Hayat S; Osman F
    Br J Hosp Med (Lond); 2017 Jun; 78(6):312-319. PubMed ID: 28614025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.
    Thibault B; Harel F; Ducharme A; White M; Ellenbogen KA; Frasure-Smith N; Roy D; Philippon F; Dorian P; Talajic M; Dubuc M; Guerra PG; Macle L; Rivard L; Andrade J; Khairy P;
    Circulation; 2013 Feb; 127(8):873-81. PubMed ID: 23388213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transvenous cardiac resynchronization therapy in congenitally corrected transposition of the great arteries and progressive heart failure.
    Bonnemeier H; Demming T
    Int J Cardiol; 2014 Apr; 172(3):e504-6. PubMed ID: 24507741
    [No Abstract]   [Full Text] [Related]  

  • 28. Echocardiographic Predictors of Response to Cardiac Resynchronization Therapy in 2016: Can Quantitative Global Parameters Succeed Where Segmental Parameters of Dyssynchrony Have Fallen Short?
    Costa SP
    Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27252360
    [No Abstract]   [Full Text] [Related]  

  • 29. Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression.
    Goldraich LA; Martinelli NC; Matte U; Cohen C; Andrades M; Pimentel M; Biolo A; Clausell N; Rohde LE
    Biomarkers; 2014 Mar; 19(2):135-41. PubMed ID: 24506564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart Failure.
    Li H; Lichter JG; Seidel T; Tomaselli GF; Bridge JH; Sachse FB
    Circ Heart Fail; 2015 Nov; 8(6):1105-14. PubMed ID: 26294422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide and promotion of cardiac myocyte apoptosis.
    Andréka P; Tran T; Webster KA; Bishopric NH
    Mol Cell Biochem; 2004 Aug; 263(1-2):35-53. PubMed ID: 15524166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in cardiomyocytes.
    Luo P; He T; Jiang R; Li G
    Mol Med Rep; 2015 Jul; 12(1):1163-8. PubMed ID: 25776937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal microRNA clusters are important for the therapeutic effect of cardiac progenitor cells.
    Sluijter JP; van Rooij E
    Circ Res; 2015 Jan; 116(2):219-21. PubMed ID: 25593269
    [No Abstract]   [Full Text] [Related]  

  • 34. [The Relationship Between Quality of Life and Psychological and Behavioral Factors in Patients With Heart Failure Following Cardiac Resynchronization Therapy].
    Huang J; Fang JB; Zhao YH
    Hu Li Za Zhi; 2018 Jun; 65(3):58-70. PubMed ID: 29790140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.
    Kumarswamy R; Anker SD; Thum T
    Circ Res; 2010 May; 106(9):e8; author reply e9. PubMed ID: 20466983
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac Resynchronization Therapy in Older Adults with Heart Failure.
    Lam PH; Taffet GE; Ahmed A; Singh S
    Heart Fail Clin; 2017 Jul; 13(3):581-587. PubMed ID: 28602373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [European Society of Cardiology guidelines on cardiac resynchronization therapy].
    Robinet S; Delcour A; Lancellotti P;
    Rev Med Liege; 2014 Apr; 69(4):180-7. PubMed ID: 24923097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-214 protects cardiac myocytes against H2O2-induced injury.
    Lv G; Shao S; Dong H; Bian X; Yang X; Dong S
    J Cell Biochem; 2014 Jan; 115(1):93-101. PubMed ID: 23904244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.